The trial is being conducted at Kaiser Permanent Washington Health Research Institute, and will test a range of doses of the vaccine. ... Mar 20
The vaccine candidate will use technology to raise strong immune responses while being well tolerated and to meet potential global demand in 2021. ... Mar 09